Post Approval Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft
Public ClinicalTrials.gov record NCT04261686. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Multi-Center, Non-Randomized Clinical Study of the BARD® COVERA Arteriovenous (AV) Stent Graft in the Treatment of Stenosis in the Venous Outflow of AV Fistula Access Circuits (AVeNEW) Post Approval Study
Study identification
- NCT ID
- NCT04261686
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- C. R. Bard
- Industry
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Interventions
- Covera Vascular Covered Stent Device
Device
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2, 2020
- Primary completion
- Sep 15, 2025
- Completion
- Sep 15, 2025
- Last update posted
- Dec 15, 2025
2020 – 2025
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Kidney Disease and Hypertension Center Medical Research Services | Phoenix | Arizona | 85012 | — |
| Yale University | New Haven | Connecticut | 06511 | — |
| Chicago Access Care | Westmont | Illinois | 60559 | — |
| Kidney Care & Transplant Services of New England | West Springfield | Massachusetts | 01089 | — |
| Michigan Vascular Center | Flint | Michigan | 48507 | — |
| University of Minnesota Medical Center | Minneapolis | Minnesota | 55455 | — |
| Minnesota Vascular and Surgery Center | New Brighton | Minnesota | 55112 | — |
| North Carolina Nephrology | Raleigh | North Carolina | 27610 | — |
| Providence Access Care | Providence | Rhode Island | 02906 | — |
| Dallas Renal Group | Dallas | Texas | 75208 | — |
| San Antonio Kidney and Disease Access Center | San Antonio | Texas | 78216 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04261686, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 15, 2025 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04261686 live on ClinicalTrials.gov.